Crunchbase is centred on companies, capital and the people behind them. Cafiyn Lens scores whether your market is worth entering. Funding is one signal, not a viability verdict.
Crunchbase is centred on companies and capital. It records companies, funding rounds, investors, acquisitions and the people attached to them, and it does that better than almost anything else you can subscribe to. It has also built prospecting tooling on top of that data, so teams use it to find accounts and to act when one of them moves. If you are raising, mapping who already exists in a category, or timing outreach at accounts that just closed a round, it is the obvious tool to open.
Cafiyn Lens holds no company records at all. It is an assessment: five modules (opportunity, ICP and buying committee, competitive intelligence, positioning, demand signals) returning a Market Viability Report with a scored verdict and every claim linked to its source, usually the same day. Each assessment writes into the Blueprint, so Cafiyn FlyWheel can run acquisition against the same market model.
Founders compare the two because both get opened in the same week: the week you are trying to work out whether a market is real. One shows you who is in it and who funded them. The other tells you whether you should enter it.
Crunchbase is centred on companies and capital: who exists, who raised, from whom, and who bought whom. It is one of the cleanest sources you can subscribe to for that, and it has built prospecting and account-tracking tooling on top of it.
Cafiyn Lens is centred on the decision that comes before the account list: whether demand is real, who the buyer is, what they pay, and whether the gap is worth entering.
Crunchbase can show you that a category is well funded and that a given account just came into money. Funding is a proxy for investor conviction, not for customer willingness to pay.
Cafiyn Lens reads the buyer side directly: search and community demand, competitor pricing pages, review sentiment and hiring patterns, then scores the verdict.
| Capability | Cafiyn Lens | Crunchbase |
|---|---|---|
| Company and funding round records | ||
| Investor and portfolio research | ||
| Tracking a watchlist of companies over time | ||
| Funding history for a company or a category | ||
| Company list building and CSV export | ||
| Competitive landscape read | ||
| Demand signal reading (search, community, hiring) | ||
| Bottom-up market sizing | ||
| ICP and buying committee map | ||
| Willingness-to-pay read | ||
| Positioning recommendation | ||
| Scored viability verdict | ||
| Works on an idea with no company record yet | ||
| Feeds outbound campaigns via the Blueprint | ||
| Pricing shape | Named tiers from $14.99/mo | Per seat, tiered plans |
*Straight SaaS pricing: Cafiyn Lens is $14.99 Focus, $29 Prism, or $49 Panorama per month, priced by the assessments included each month. No revenue share. See full pricing.
Feature availability, pricing, and timelines reflect publicly available information at the time of comparison and may change. Time-to-meeting and time-to-revenue figures are indicative, not guarantees; results depend on product quality, market demand, pricing, and audience.
The honest split: Crunchbase answers questions about capital, companies and which accounts to approach, Lens answers questions about markets and buyers. Neither covers the other, and a heavily funded category is evidence of investor conviction, not proof of a gap you can enter.
If your next move is a raise, an investor list, a map of who already exists, or an account list to work, buy Crunchbase and skip Lens. If your next move is deciding whether to build, and then who to sell to and how, Lens is the one that ends in a verdict instead of a spreadsheet. Tiers start at Focus, $14.99 a month for five assessments, with Prism and Panorama above it, and annual billing takes 20% off. Entry today is an application-reviewed waitlist, not a checkout.
Only if what you actually wanted was a market read rather than a company database. Lens is not built to tell you who led a Series B or which funds back a category, because it keeps no funding records at all. It answers the other question: whether demand, buyer, competition and pricing support the idea you are weighing. If you need company and funding data, Crunchbase is the right tool and Lens is not a substitute for it.
It evidences one thing well: that investors believe a category is worth funding, and which companies are already in it. That is real evidence, and a category with a decade of rounds behind it is rarely imaginary. What company and funding data cannot show you is the customer side: who buys, what they pay, why they churn, and whether the funded incumbents left a gap or closed it. Heavy funding reads as both opportunity and saturation, and funding data alone cannot tell you which.
If you raise money, or sell into funded companies, yes. Crunchbase is one of the cleanest places to see rounds, investors and acquisitions, and a fresh raise is a genuinely good buying trigger. Lens keeps none of that. The split most teams land on is simple: Lens for the market assessment and the plan, Crunchbase for capital research and for timing outreach at accounts that just raised.
Five modules: opportunity assessment, ICP and buying committee discovery, competitive intelligence, positioning, and demand signals. The inputs are buyer side: search and community demand, competitor pricing pages, review sentiment, hiring patterns and public product claims. They return sub-scores inside one Market Viability Report with a scored verdict and every claim linked to its source, usually the same day. Funding context can inform the competitive module, but it is never the verdict.
A decision-grade market read with sources attached, usually the same day. Straight SaaS from $14.99/mo, cancel anytime.